PFE (Pfizer) How high will it go? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go?

PFE 25.34

-1.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Perry who wrote (948)	4/3/1998 2:40:00 PM
From: Brian Malloy	Read Replies (2) of 9523

As the link below shows, even small companies in the ED market can test their products utilizing large numbers. The following is for MUSE produced by VIVUS (VVUS) The New England Journal of Medicine -- January 2, 1997 -- Volume 336, Number 1 Treatment of Men with Erectile Dysfunction with Transurethral Alprostadil Methods. Alprostadil was delivered transurethrally in a double-blind, placebo-controlled study of 1511 men, 27 to 88 years of age, who had chronic erectile dysfunction from various organic causes. nejm.org

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next